Transgene’s Cancer Vaccine Abandoned after Phase II Fail
French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to…
French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to…
Biotech companies around the world gathered in Barcelona, Spain, to present breakthroughs in cancer diagnostics…
A phase III trial testing an oncolytic virus treatment for liver cancer, developed by the…
Although biotech may seem like an industry that has only just gotten started, it was…
Transgene will help Servier develop new methods based on viral vectors to improve the precision…
After positive results in Phase I, Transgene has started Phase II with Pexa-Vec in combination…
Transgene is partnering with Merck and Pfizer to develop a combined therapy for head and…
Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why?…
The annual meeting of the American Association for Cancer Research (AACR) has just finished. From…
This multinational Phase III Trial for an Oncolytic Immunotherapy for Advanced Liver Cancer could be…
Transgene, the oldest French Biotech company announced just yesterday that it will cut 120 jobs…